| Meningococcal B Vaccine in Patients with Asplenia (NCT06025487) | Medical University of Vienna | 2024-03-12 |
| The Effect of Naldemedine on Opioid-induced Bowel Dysfunction (NCT06334198) | Asbjørn Mohr Drewes | 2024-03-12 |
| iTBS+D-Cycloserine for Youth Suicide (NCT06121284) | University of Calgary | 2024-03-11 |
| RECOVER-AUTONOMIC Platform Protocol (NCT06305780) | Kanecia Obie Zimmerman | 2024-03-11 |
| Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery (NCT05943119) | Centre Francois Baclesse | 2024-03-11 |
| Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment (NCT06751901) | The First Affiliated Hospital of Nanchang University | 2024-03-11 |
| RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine) (NCT06305806) | Kanecia Obie Zimmerman | 2024-03-11 |
| Effects of Ketone Supplementation on Acute Alcohol Withdrawal (NCT06173973) | University of Pennsylvania | 2024-03-11 |
| Dostarlimab and Cobolimab in Advanced Cervical Cancer (NCT06238635) | Meghan Shea | 2024-03-11 |
| A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia (NCT06368414) | Korean Society of Hematology | 2024-03-11 |
| Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) (NCT06266338) | University of Texas Southwestern Medical Center | 2024-03-11 |
| Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment (NCT06751849) | The First Affiliated Hospital of Nanchang University | 2024-03-11 |
| Comparative Analysis of Biomarkers in Response to Acute Moderate-Intensity Activity (NCT06217068) | University of Georgia | 2024-03-11 |
| Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion (NCT06029998) | University of Utah | 2024-03-11 |
| T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer (NCT05586360) | Medical University of South Carolina | 2024-03-11 |
| Oral Supplementation During PR Participation in COPD (NCT06324214) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2024-03-11 |
| Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer (NCT06247956) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-03-11 |
| Twin Block, Pain Medications and Third Molar Extractions (NCT04880707) | Rutgers, The State University of New Jersey | 2024-03-11 |
| Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma (NCT06151236) | Melanoma Institute Australia | 2024-03-11 |
| Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology (NCT06378190) | Instituto de Investigación Biomédica de Salamanca | 2024-03-11 |
| DORA and LP in Alzheimer's Disease Biomarkers (NCT06274528) | University of Minnesota | 2024-03-11 |
| Evaluation of Canakinumab in High-Risk Former-Smokers (NCT06038526) | Peter Shields | 2024-03-11 |
| DePTH: De-emphasize PTH (NCT06288451) | University of Washington | 2024-03-11 |
| Fecal Microbiome Transplantation From Healthy Donors to Individuals With Fibromyalgia (NCT06424041) | Rambam Health Care Campus | 2024-03-11 |
| Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma (NCT06215651) | Peking Union Medical College Hospital | 2024-03-11 |
| Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) (NCT05355272) | Baylor College of Medicine | 2024-03-11 |
| Polypill for Prevention of Cardiomyopathy (NCT06143566) | University of Texas Southwestern Medical Center | 2024-03-11 |
| Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma (NCT06339619) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-03-11 |
| Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI (NCT07138508) | Ain Shams University | 2024-03-10 |
| The Effect of PRP on Wound Healing in High Risk Patients Undergoing Abdominal Hysterectomy (NCT06298110) | Helwan University | 2024-03-10 |
| NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study (NCT06345300) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-03-10 |
| SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer (NCT06266871) | West China Hospital | 2024-03-10 |
| Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401) (NCT06261125) | Mian XI | 2024-03-10 |
| Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease (NCT05725902) | Novo Nordisk A/S | 2024-03-09 |
| A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors (NCT06292208) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2024-03-09 |
| Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial (NCT06308939) | Zhejiang Cancer Hospital | 2024-03-08 |
| A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NCT06354530) | Army Medical Center of PLA | 2024-03-08 |
| Non-Viral TCR Gene Therapy (NCT04102436) | National Cancer Institute (NCI) | 2024-03-08 |
| Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) (NCT06048133) | Nataliya Uboha | 2024-03-08 |
| A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities (NCT06277934) | Regor Pharmaceuticals Inc. | 2024-03-08 |
| LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery (NCT05879432) | Arch Biopartners Inc. | 2024-03-08 |
| Elranatamab in R/R Multiple Myeloma (NCT06138275) | Massachusetts General Hospital | 2024-03-08 |
| Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer (NCT05730712) | Mayo Clinic | 2024-03-08 |
| Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (NCT06240143) | The Netherlands Cancer Institute | 2024-03-08 |
| A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population. (NCT06290375) | Xizang Haisco Pharmaceutical Co., Ltd | 2024-03-08 |
| Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements (NCT05987644) | Joshua Palmer | 2024-03-07 |
| Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients (NCT06388642) | Clinuvel Europe Limited | 2024-03-07 |
| Radiation Therapy in Unresectable Gall Bladder Cancer (NCT06214572) | Tata Memorial Centre | 2024-03-07 |
| Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT06118788) | Guangzhou Bio-gene Technology Co., Ltd | 2024-03-07 |
| Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL) (NCT06088381) | University of Maryland, Baltimore | 2024-03-07 |
| Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI (NCT06286059) | Helwan University | 2024-03-07 |
| Study of 23ME-01473 in Patients With Advanced Solid Malignancies (NCT06290388) | 23andMe, Inc. | 2024-03-07 |
| A Study for HSK39775 in Participants With Solid Tumors (NCT06314373) | Xizang Haisco Pharmaceutical Co., Ltd | 2024-03-07 |
| A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis (NCT05646381) | Novartis Pharmaceuticals | 2024-03-07 |
| Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy (NCT05933434) | Aarhus University Hospital | 2024-03-07 |
| First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC (NCT05745350) | Xiaorong Dong | 2024-03-07 |
| Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty (NCT06398275) | University Hospital of Split | 2024-03-06 |
| An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD (NCT06237426) | Transcend Therapeutics | 2024-03-06 |
| Ketones in Heart Failure With Reduced Ejection Fraction (NCT06195982) | Duke University | 2024-03-06 |
| Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder. (NCT06290258) | Chang Gung Memorial Hospital | 2024-03-06 |
| Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan (NCT06108063) | Steadman Philippon Research Institute | 2024-03-06 |
| A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer (NCT05567835) | Baylor College of Medicine | 2024-03-06 |
| TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies (NCT06206174) | Shenzhen TargetRx Co., Ltd. | 2024-03-06 |
| Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer (NCT06362317) | Peking Union Medical College Hospital | 2024-03-06 |
| A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa (NCT05868733) | International AIDS Vaccine Initiative | 2024-03-06 |
| Personalized Brain Stimulation to Treat Chronic Concussive Symptoms (NCT06073886) | University of California, Los Angeles | 2024-03-06 |
| Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor (NCT06105021) | Affini-T Therapeutics, Inc. | 2024-03-06 |
| A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC (NCT06306456) | Suzhou Genhouse Bio Co., Ltd. | 2024-03-05 |
| Digital Health Intervention to Improve Health Care and Outcomes for Breast Cancer Patients (NCT05925257) | Coordinación de Investigación en Salud, Mexico | 2024-03-05 |
| IVIM & OLINK in Sarcoma (NCT05950594) | University Health Network, Toronto | 2024-03-05 |
| A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment (NCT06239116) | Rhythm Pharmaceuticals, Inc. | 2024-03-05 |
| Title: Leveraging Technology to Address Health Outcomes of Cancer Survivors (NCT05499663) | University of Maryland, Baltimore | 2024-03-05 |
| Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA (NCT05839535) | Massachusetts General Hospital | 2024-03-05 |
| Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma (NCT04838652) | University of Cologne | 2024-03-05 |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease (NCT06233461) | Takeda | 2024-03-05 |
| EFFECT OF A SUBSTANCE P ANTAGONIST ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME AND ARTERIAL HYPERTENSION (NCT06462287) | University Hospital, Rouen | 2024-03-05 |
| Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (NCT06075745) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-03-05 |
| The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism (NCT06162013) | Haukeland University Hospital | 2024-03-05 |
| CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations (NCT05689021) | Mayo Clinic | 2024-03-05 |
| FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT06402331) | Fusion Pharmaceuticals Inc. | 2024-03-05 |
| A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease (NCT06226545) | Lassen Therapeutics Inc. | 2024-03-05 |
| Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients (NCT06016972) | Qlaris Bio, Inc. | 2024-03-05 |
| Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment (NCT06031259) | Takeda | 2024-03-05 |
| Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children (NCT06099366) | Hee Young Ju | 2024-03-05 |
| Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors (NCT06176989) | National Cancer Institute (NCI) | 2024-03-04 |
| A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD (NCT05643638) | Cynata Therapeutics Limited | 2024-03-04 |
| Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy (NCT06145035) | Roberto Bolli | 2024-03-04 |
| Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC) (NCT06189209) | Rhizen Pharmaceuticals SA | 2024-03-04 |
| Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (NCT06238115) | Beijing Tiantan Hospital | 2024-03-04 |
| Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D) (NCT06305286) | University of Chicago | 2024-03-04 |
| Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma (NCT06314334) | Fudan University | 2024-03-04 |
| Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy (NCT06138743) | Sarepta Therapeutics, Inc. | 2024-03-04 |
| Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma (NCT06088654) | Innate Pharma | 2024-03-04 |
| HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC (NCT06364007) | Sulai Liu | 2024-03-03 |
| "Dexa vs Dexmedetomidine With Bupivacaine in TAP Block for Laparotomy Analgesia (NCT07590752) | Sahiwal medical college sahiwal | 2024-03-03 |
| Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS (NCT06247917) | Ruijin Hospital | 2024-03-03 |
| Ultrasonic Treatment of Food Addiction (NCT06249711) | University of Utah | 2024-03-03 |
| Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease (NCT06221059) | Shandong Suncadia Medicine Co., Ltd. | 2024-03-02 |
| Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006) (NCT06143748) | Sun Yat-sen University | 2024-03-02 |
| Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women (NCT06220266) | Dhurakij Pundit University | 2024-03-02 |